SCHEMBL13628838

SCHEMBL13628838

COOSc1cnc2c(c1)cc(-c1ccc(C)o1)n2Cc1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.36
CYP3A4 P08684 9/20 0.36
TSHR P16473 6/20 0.36
CYP2C9 P11712 6/20 0.36
USP2 O75604 6/20 0.36
CYP2C19 P33261 5/20 0.36
CNR1 P21554 4/20 0.34
CNR2 P34972 4/20 0.34
ADORA2A P29274 2/20 0.34
ALDH1A1 P00352 6/20 0.33
HSD17B10 Q99714 4/20 0.33
CASP1 P29466 3/20 0.33
CASP7 P55210 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP2D6 P10635 2/20 0.33
BRCA1 P38398 1/20 0.33
HIF1A Q16665 3/20 0.32
HPGD P15428 2/20 0.32
MAPK1 P28482 2/20 0.32
CDK9 P50750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13628819 0.85 CNR1 (0.43) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628825 0.82 CYP1A2 (0.37) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628822 0.81 CYP1A2 (0.37) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628861 0.80 RAB9A (0.38) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628831 0.80 MCL1 (0.39) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628864 0.79 CYP1A2 (0.39) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL2924583 0.78 PTGS2 (0.41) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628855 0.77 CYP1A2 (0.33) CYP1A2CYP3A4TSHRCYP2C9USP2
SCHEMBL13628856 0.74 CNR2 (0.40) CNR1CNR2TP53LMNA
SCHEMBL13628857 0.72 CCR2 (0.40) CYP1A2CYP3A4TSHRCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612070-B2 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-11-03 US disclosed